William Sievert

William Sievert

Monash University

H-index: 54

Oceania-Australia

About William Sievert

William Sievert, With an exceptional h-index of 54 and a recent h-index of 36 (since 2020), a distinguished researcher at Monash University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Human amniotic epithelial cell transplantation is safe and well tolerated in patients with compensated cirrhosis: a first-in-human trial

Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network

Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open …

Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants

Hepatitis C virus in people with serious mental illness: an analysis of the care cascade at a tertiary health service with a pilot ‘identify and treat’strategy

Hepatitis B Virus Flares After Nucleot (s) ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

William Sievert Information

University

Position

___

Citations(all)

18877

Citations(since 2020)

7459

Cited By

14486

hIndex(all)

54

hIndex(since 2020)

36

i10Index(all)

137

i10Index(since 2020)

77

Email

University Profile Page

Google Scholar

Top articles of William Sievert

Human amniotic epithelial cell transplantation is safe and well tolerated in patients with compensated cirrhosis: a first-in-human trial

Stem Cells Translational Medicine

2024/4/15

William Sievert
William Sievert

H-Index: 33

Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care

Journal of gastroenterology and hepatology

2024/3

Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network

Internal Medicine Journal

2023/9

Danny Liew
Danny Liew

H-Index: 41

William Sievert
William Sievert

H-Index: 33

Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open …

EBioMedicine

2023/12/1

William Sievert
William Sievert

H-Index: 33

Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants

Hepatology Communications

2023/8/1

Dilip Ratnam
Dilip Ratnam

H-Index: 6

William Sievert
William Sievert

H-Index: 33

Hepatitis C virus in people with serious mental illness: an analysis of the care cascade at a tertiary health service with a pilot ‘identify and treat’strategy

Internal Medicine Journal

2023/5

Hepatitis B Virus Flares After Nucleot (s) ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

The Journal of infectious diseases

2023/1/1

Dilip Ratnam
Dilip Ratnam

H-Index: 6

William Sievert
William Sievert

H-Index: 33

Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease

Liver International

2023/1

William Sievert
William Sievert

H-Index: 33

Liver disease and poor adherence limit hepatitis C cure: a real-world Australian treatment cohort

Digestive Diseases and Sciences

2023/1

Jacob George
Jacob George

H-Index: 21

William Sievert
William Sievert

H-Index: 33

Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial

Nutrients

2023/11/22

William Sievert
William Sievert

H-Index: 33

Barbora De Courten
Barbora De Courten

H-Index: 44

First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection

Journal of Hepatology

2023/11/1

Stopping nucleot (s) ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

Alimentary Pharmacology & Therapeutics

2022/7

Dilip Ratnam
Dilip Ratnam

H-Index: 6

William Sievert
William Sievert

H-Index: 33

13: LOCAL PERI-FISTULA INJECTION OF A NOVEL PLACENTA-DERIVED CELL IS A SAFE AND PROMISING TREATMENT FOR REFRACTORY COMPLEX FISTULIZING PERIANAL CROHN'S DISEASE: A PHASE I OPEN …

Gastroenterology

2022/5/1

William Sievert
William Sievert

H-Index: 33

Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB

Journal of hepatology

2022/11/1

LivR Well, a 28-day, community-based liver optimization program for patients with acute-on-chronic liver failure: A feasibility study.

Journal of Gastroenterology and Hepatology

2022/10/21

Fourier-Transform Infra-Red Microspectroscopy Can Accurately Diagnose Colitis and Assess Severity of Inflammation

International Journal of Molecular Sciences

2022/3/5

See List of Professors in William Sievert University(Monash University)